These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 17658302)

  • 1. A German external quality survey of diagnostic microbiology of respiratory tract infections in patients with cystic fibrosis.
    Balke B; Schmoldt S; Häussler S; Suerbaum S; Heesemann J; Hogardt M
    J Cyst Fibros; 2008 Jan; 7(1):7-14. PubMed ID: 17658302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EuroCareCF quality assessment of diagnostic microbiology of cystic fibrosis isolates.
    Hogardt M; Ulrich J; Riehn-Kopp H; Tümmler B
    J Clin Microbiol; 2009 Nov; 47(11):3435-8. PubMed ID: 19741077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Compliance of clinical microbiology laboratories in the United States with current recommendations for processing respiratory tract specimens from patients with cystic fibrosis.
    Zhou J; Garber E; Desai M; Saiman L
    J Clin Microbiol; 2006 Apr; 44(4):1547-9. PubMed ID: 16597890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Staphylococcus aureus and Pseudomonas aeruginosa Isolates from the Same Cystic Fibrosis Respiratory Sample Coexist in Coculture.
    Bernardy EE; Raghuram V; Goldberg JB
    Microbiol Spectr; 2022 Aug; 10(4):e0097622. PubMed ID: 35867391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of microbiological diagnostic procedures for respiratory specimens from cystic fibrosis patients in German laboratories by use of a questionnaire.
    Häfner L; Peters G; Kahl BC
    J Clin Microbiol; 2014 Mar; 52(3):977-9. PubMed ID: 24391197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Microbiological diagnosis of bronchopulmonary colonization-infection in cystic fibrosis].
    Oliver A; Alarcón T; Caballero E; Cantón R
    Enferm Infecc Microbiol Clin; 2009 Feb; 27(2):89-104. PubMed ID: 19232782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of co-colonizing cystic fibrosis-associated pathogens by Pseudomonas aeruginosa and Burkholderia multivorans.
    Costello A; Reen FJ; O'Gara F; Callaghan M; McClean S
    Microbiology (Reading); 2014 Jul; 160(Pt 7):1474-1487. PubMed ID: 24790091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The changing prevalence of pulmonary infection in adults with cystic fibrosis: A longitudinal analysis.
    Ramsay KA; Sandhu H; Geake JB; Ballard E; O'Rourke P; Wainwright CE; Reid DW; Kidd TJ; Bell SC
    J Cyst Fibros; 2017 Jan; 16(1):70-77. PubMed ID: 27515017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genotypic and Phenotypic Diversity of Staphylococcus aureus Isolates from Cystic Fibrosis Patient Lung Infections and Their Interactions with Pseudomonas aeruginosa.
    Bernardy EE; Petit RA; Raghuram V; Alexander AM; Read TD; Goldberg JB
    mBio; 2020 Jun; 11(3):. PubMed ID: 32576671
    [No Abstract]   [Full Text] [Related]  

  • 10. Microbiological diagnostic procedures for respiratory cystic fibrosis samples in Spain: towards standard of care practices.
    Caballero Jde D; del Campo R; Tato M; Gómez G de la Pedrosa E; Cobo M; López-Causapé C; Gómez-Mampaso E; Oliver A; Cantón R;
    BMC Microbiol; 2014 Dec; 14():335. PubMed ID: 25927861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Staphylococcus aureus in the airways of cystic fibrosis patients - A retrospective long-term study.
    Schwerdt M; Neumann C; Schwartbeck B; Kampmeier S; Herzog S; Görlich D; Dübbers A; Große-Onnebrink J; Kessler C; Küster P; Schültingkemper H; Treffon J; Peters G; Kahl BC
    Int J Med Microbiol; 2018 Aug; 308(6):631-639. PubMed ID: 29501453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isolation and identification of Burkholderia cepacia by participants in an external Quality Assurance Program (QAP) between 1994 and 1999.
    Taylor PC; McLaws ML; De Borde M; Pritchard R
    Pathology; 2004 Aug; 36(4):352-7. PubMed ID: 15370136
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Limoli DH; Whitfield GB; Kitao T; Ivey ML; Davis MR; Grahl N; Hogan DA; Rahme LG; Howell PL; O'Toole GA; Goldberg JB
    mBio; 2017 Mar; 8(2):. PubMed ID: 28325763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extensive cultivation of soil and water samples yields various pathogens in patients with cystic fibrosis but not Burkholderia multivorans.
    Peeters C; Depoorter E; Praet J; Vandamme P
    J Cyst Fibros; 2016 Nov; 15(6):769-775. PubMed ID: 26996269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathophysiology and management of pulmonary infections in cystic fibrosis.
    Gibson RL; Burns JL; Ramsey BW
    Am J Respir Crit Care Med; 2003 Oct; 168(8):918-51. PubMed ID: 14555458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Current microbiological data on lower respiratory tract infection in cystic fibrosis. Part I: Isolated microorganisms and their clinical significance].
    Coman G; Petraru E; Dahorea C; Anton DT
    Rev Med Chir Soc Med Nat Iasi; 2012; 116(2):580-7. PubMed ID: 23077957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accuracy of four commercial systems for identification of Burkholderia cepacia and other gram-negative nonfermenting bacilli recovered from patients with cystic fibrosis.
    Kiska DL; Kerr A; Jones MC; Caracciolo JA; Eskridge B; Jordan M; Miller S; Hughes D; King N; Gilligan PH
    J Clin Microbiol; 1996 Apr; 34(4):886-91. PubMed ID: 8815102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypermutation in Burkholderia cepacia complex is mediated by DNA mismatch repair inactivation and is highly prevalent in cystic fibrosis chronic respiratory infection.
    Martina P; Feliziani S; Juan C; Bettiol M; Gatti B; Yantorno O; Smania AM; Oliver A; Bosch A
    Int J Med Microbiol; 2014 Nov; 304(8):1182-91. PubMed ID: 25217078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Belfast Agar-a simple laboratory medium to separate Pseudomonas aeruginosa from pan-resistant Burkholderia cenocepacia isolated from the sputum of patients with cystic fibrosis (CF).
    Caskey S; Moore JE; McCaughan J; Rendall JC
    Br J Biomed Sci; 2018 Apr; 75(2):101-103. PubMed ID: 29513134
    [No Abstract]   [Full Text] [Related]  

  • 20. Bronchoalveolar lavage or oropharyngeal cultures to identify lower respiratory pathogens in infants with cystic fibrosis.
    Armstrong DS; Grimwood K; Carlin JB; Carzino R; Olinsky A; Phelan PD
    Pediatr Pulmonol; 1996 May; 21(5):267-75. PubMed ID: 8726151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.